DBV Technologies (DBVT) Operating Margin Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,211.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,993.00 |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -435,755.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -435,755.00 |
| Dec 31, 2025 | -990,007.00 |
| Sep 30, 2025 | -36,680.00 |
| Jun 30, 2025 | -124,813.00 |
| Mar 31, 2025 | -266,628.00 |
| Dec 31, 2024 | -420,982.00 |
| Sep 30, 2024 | -98,723.00 |
| Jun 30, 2024 | -82,256.00 |
| Mar 31, 2024 | -102,209.00 |
| Dec 31, 2023 | -344,792.00 |
| Sep 30, 2023 | -5,439.00 |
| Jun 30, 2023 | 22,518.00 |
| Mar 31, 2023 | -9,133.00 |
| Sep 30, 2022 | 32,082.00 |
| Dec 31, 2021 | -93,438.00 |
| Sep 30, 2021 | -36,492.00 |
| Dec 31, 2018 | 94,529.00 |